Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium

Ping Chen, Shanming Hu, Jianrong Yao, Steven A. Moore, Arthur A. Spector, Xiang Fang

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Anandamide (AEA), an endogenous cannabinoid receptor agonist, is a potent vasodilator in the cerebral microcirculation. AEA is converted to arachidonic acid (AA) by fatty acid amidohydrolase (FAAH), and the conversion of AA to prostaglandins has been proposed as a potential mechanism for the vasodilation. Although AEA stimulated prostaglandin production by mouse cerebral microvascular endothelial cells, no [3H]prostaglandins were produced when these cells were incubated with [3H]AEA. Incubation with R(+)-methanandamide (MAEA), a stable analogue of AEA that is not a substrate for FAAH, produced a similar increase in PGE2 production as AEA. The PGE2 production induced by either AEA or MAEA was completely inhibited by NS-398, a selective cyclooxygenase (COX)-2 inhibitor, suggesting that COX-2 was induced. AEA and MAEA increased the expression of COX-2 protein in a time-dependent manner. This increase occurred as early as 1 h and reached maximum at 2 h. Induction of COX-2 protein by AEA was partially inhibited by AM-251, a selective cannabinoid receptor-1 antagonist. Furthermore, AEA increased COX-2 promoter activity approximately twofold above baseline in a fragment ranging from -1432 to +59, the full-length of the COX-2 promoter, and the increase in COX-2 promoter activity produced by AEA was partially inhibited by AM-251. These results indicate that AEA increased COX-2 expression at the transcriptional level through, at least in part, a cannabinoid receptor-1-mediated mechanism in cerebral microvascular endothelium.

Original languageEnglish (US)
Pages (from-to)28-35
Number of pages8
JournalMicrovascular Research
Volume69
Issue number1-2
DOIs
StatePublished - Jan 2005
Externally publishedYes

Fingerprint

Cyclooxygenase 2
Endothelium
Amidohydrolases
Prostaglandins
Cannabinoid Receptors
Dinoprostone
Arachidonic Acid
Fatty Acids
Cannabinoid Receptor Antagonists
Cannabinoid Receptor Agonists
Microcirculation
Cyclooxygenase 2 Inhibitors
Endothelial cells
anandamide
Vasodilator Agents
Vasodilation
Proteins
Endothelial Cells
Substrates

Keywords

  • Anandamide
  • Cannabinoid receptor
  • Cyclooxgenase-2
  • Endothelial cells

ASJC Scopus subject areas

  • Biochemistry
  • Cardiology and Cardiovascular Medicine

Cite this

Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium. / Chen, Ping; Hu, Shanming; Yao, Jianrong; Moore, Steven A.; Spector, Arthur A.; Fang, Xiang.

In: Microvascular Research, Vol. 69, No. 1-2, 01.2005, p. 28-35.

Research output: Contribution to journalArticle

Chen, Ping ; Hu, Shanming ; Yao, Jianrong ; Moore, Steven A. ; Spector, Arthur A. ; Fang, Xiang. / Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium. In: Microvascular Research. 2005 ; Vol. 69, No. 1-2. pp. 28-35.
@article{e4e727d44b0748ca8ea2f7a74c4c31a9,
title = "Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium",
abstract = "Anandamide (AEA), an endogenous cannabinoid receptor agonist, is a potent vasodilator in the cerebral microcirculation. AEA is converted to arachidonic acid (AA) by fatty acid amidohydrolase (FAAH), and the conversion of AA to prostaglandins has been proposed as a potential mechanism for the vasodilation. Although AEA stimulated prostaglandin production by mouse cerebral microvascular endothelial cells, no [3H]prostaglandins were produced when these cells were incubated with [3H]AEA. Incubation with R(+)-methanandamide (MAEA), a stable analogue of AEA that is not a substrate for FAAH, produced a similar increase in PGE2 production as AEA. The PGE2 production induced by either AEA or MAEA was completely inhibited by NS-398, a selective cyclooxygenase (COX)-2 inhibitor, suggesting that COX-2 was induced. AEA and MAEA increased the expression of COX-2 protein in a time-dependent manner. This increase occurred as early as 1 h and reached maximum at 2 h. Induction of COX-2 protein by AEA was partially inhibited by AM-251, a selective cannabinoid receptor-1 antagonist. Furthermore, AEA increased COX-2 promoter activity approximately twofold above baseline in a fragment ranging from -1432 to +59, the full-length of the COX-2 promoter, and the increase in COX-2 promoter activity produced by AEA was partially inhibited by AM-251. These results indicate that AEA increased COX-2 expression at the transcriptional level through, at least in part, a cannabinoid receptor-1-mediated mechanism in cerebral microvascular endothelium.",
keywords = "Anandamide, Cannabinoid receptor, Cyclooxgenase-2, Endothelial cells",
author = "Ping Chen and Shanming Hu and Jianrong Yao and Moore, {Steven A.} and Spector, {Arthur A.} and Xiang Fang",
year = "2005",
month = "1",
doi = "10.1016/j.mvr.2005.02.001",
language = "English (US)",
volume = "69",
pages = "28--35",
journal = "Microvascular Research",
issn = "0026-2862",
publisher = "Academic Press Inc.",
number = "1-2",

}

TY - JOUR

T1 - Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium

AU - Chen, Ping

AU - Hu, Shanming

AU - Yao, Jianrong

AU - Moore, Steven A.

AU - Spector, Arthur A.

AU - Fang, Xiang

PY - 2005/1

Y1 - 2005/1

N2 - Anandamide (AEA), an endogenous cannabinoid receptor agonist, is a potent vasodilator in the cerebral microcirculation. AEA is converted to arachidonic acid (AA) by fatty acid amidohydrolase (FAAH), and the conversion of AA to prostaglandins has been proposed as a potential mechanism for the vasodilation. Although AEA stimulated prostaglandin production by mouse cerebral microvascular endothelial cells, no [3H]prostaglandins were produced when these cells were incubated with [3H]AEA. Incubation with R(+)-methanandamide (MAEA), a stable analogue of AEA that is not a substrate for FAAH, produced a similar increase in PGE2 production as AEA. The PGE2 production induced by either AEA or MAEA was completely inhibited by NS-398, a selective cyclooxygenase (COX)-2 inhibitor, suggesting that COX-2 was induced. AEA and MAEA increased the expression of COX-2 protein in a time-dependent manner. This increase occurred as early as 1 h and reached maximum at 2 h. Induction of COX-2 protein by AEA was partially inhibited by AM-251, a selective cannabinoid receptor-1 antagonist. Furthermore, AEA increased COX-2 promoter activity approximately twofold above baseline in a fragment ranging from -1432 to +59, the full-length of the COX-2 promoter, and the increase in COX-2 promoter activity produced by AEA was partially inhibited by AM-251. These results indicate that AEA increased COX-2 expression at the transcriptional level through, at least in part, a cannabinoid receptor-1-mediated mechanism in cerebral microvascular endothelium.

AB - Anandamide (AEA), an endogenous cannabinoid receptor agonist, is a potent vasodilator in the cerebral microcirculation. AEA is converted to arachidonic acid (AA) by fatty acid amidohydrolase (FAAH), and the conversion of AA to prostaglandins has been proposed as a potential mechanism for the vasodilation. Although AEA stimulated prostaglandin production by mouse cerebral microvascular endothelial cells, no [3H]prostaglandins were produced when these cells were incubated with [3H]AEA. Incubation with R(+)-methanandamide (MAEA), a stable analogue of AEA that is not a substrate for FAAH, produced a similar increase in PGE2 production as AEA. The PGE2 production induced by either AEA or MAEA was completely inhibited by NS-398, a selective cyclooxygenase (COX)-2 inhibitor, suggesting that COX-2 was induced. AEA and MAEA increased the expression of COX-2 protein in a time-dependent manner. This increase occurred as early as 1 h and reached maximum at 2 h. Induction of COX-2 protein by AEA was partially inhibited by AM-251, a selective cannabinoid receptor-1 antagonist. Furthermore, AEA increased COX-2 promoter activity approximately twofold above baseline in a fragment ranging from -1432 to +59, the full-length of the COX-2 promoter, and the increase in COX-2 promoter activity produced by AEA was partially inhibited by AM-251. These results indicate that AEA increased COX-2 expression at the transcriptional level through, at least in part, a cannabinoid receptor-1-mediated mechanism in cerebral microvascular endothelium.

KW - Anandamide

KW - Cannabinoid receptor

KW - Cyclooxgenase-2

KW - Endothelial cells

UR - http://www.scopus.com/inward/record.url?scp=15744382273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15744382273&partnerID=8YFLogxK

U2 - 10.1016/j.mvr.2005.02.001

DO - 10.1016/j.mvr.2005.02.001

M3 - Article

C2 - 15797258

AN - SCOPUS:15744382273

VL - 69

SP - 28

EP - 35

JO - Microvascular Research

JF - Microvascular Research

SN - 0026-2862

IS - 1-2

ER -